Cargando…
Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia: Two Randomized Phase 2 Studies
PURPOSE: To determine the safety, efficacy, and tolerability of combinations of pilocarpine (Pilo) and oxymetazoline (Oxy) ocular drops dosed once daily and identify the optimal concentration of each for the pharmacologic treatment of presbyopia. DESIGN: Two concurrent Phase 2, multicenter, double-m...
Autores principales: | Price, Francis W., Hom, Milton, Moshirfar, Majid, Evans, David, Liu, Haixia, Penzner, Jeff, Robinson, Michael R., Lee, Sungwook, Wirta, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562347/ https://www.ncbi.nlm.nih.gov/pubmed/36246939 http://dx.doi.org/10.1016/j.xops.2021.100065 |
Ejemplares similares
-
In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia Treatment
por: Jackson, Mitchell A., et al.
Publicado: (2022) -
Safety and Efficacy of AGN-190584 in Individuals With Presbyopia: The GEMINI 1 Phase 3 Randomized Clinical Trial
por: Waring, George O., et al.
Publicado: (2022) -
Pilocarpine 1.25% for the treatment of presbyopia
por: Mansoori, Tarannum
Publicado: (2023) -
Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results
por: Bacharach, Jason, et al.
Publicado: (2021) -
Corneal Refractive Procedures for the Treatment of Presbyopia
por: Moussa, Kareem, et al.
Publicado: (2017)